Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Riffo-Vasquez, A. Somani, C. Page (London, United Kingdom). The effect of N acetyl-de-O-sulphated heparin on leukocyte diapedesis in vivo. Eur Respir J 2013; 42: Suppl. 57, 1761

Member's Comments

No comment yet.

Related content which might interest you: Effect of doxofylline on LPS-induced leukocyte migration to the lung Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Demonstration of anti-inflammatory properties of an inhaled p38 inhibitor AZD7624 Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 The anti-inflammatory effects of PF03715455 and roflumilast on both cellular and tissue inflammation in a mouse model of COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Effect of the combination of doxofylline and montelukast on LPS-induced leukocyte migration to the lung Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 The anti-inflammatory effects of eucalyptol in a mouse model of LPS-induced pulmonary inflammation are mediated by TRPM8 Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 CXCR1 is dispensable for allergy-driven airway leukocyte recruitment in vivo Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Effect of MSC treatment on LPS-induced inflammation, emphysema and atherosclerosis in E3L mice Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Osteopontin binds and modulate the antibacterial action of eosinophil-recruiting chemokines during allergic inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Systemic characterization of macrophage phenotypes in allergic airway inflammation Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Effect of human neutrophil proteases on ex vivo small airway function Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Synergistic suppression of T cell-induced eosinophilia by CTLA4-Ig and glucocorticoid in murine asthma model Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Regulatory B cell development by helminth-derived antigens Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Aerobic training reverses airway inflammation by increasing the expression of anti-inflammatory cytokines by peribronchial cells but not by skeletal muscle Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Lung inflammation: The role of alveolar macrophages Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Regulation of inflammatory cytokines in human immunocompetent cells by propranolol in vitro Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Bcl-2 antagonist ABT-737 attenuates corticosteroid-insensitive neutrophilic airway inflammation Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015